TCIM
CVS icon

TIAA CREF Investment Management’s CVS Health CVS Stock Holding History

TIAA CREF Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$369M Sell
6,842,868
-1,768,121
-21% -$109M 0.26% 75
2018
Q4 		$564M Buy
8,610,989
+2,226,239
+35% +$166M 0.45% 43
2018
Q3 		$503M Buy
6,384,750
+971,325
+18% +$69.4M 0.33% 64
2018
Q2 		$348M Buy
5,413,425
+2,359,028
+77% +$155M 0.23% 91
2018
Q1 		$190M Buy
3,054,397
+92,262
+3% +$6.62M 0.13% 167
2017
Q4 		$215M Sell
2,962,135
-250,151
-8% -$18.2M 0.14% 153
2017
Q3 		$261M Buy
3,212,286
+151,714
+5% +$12M 0.18% 123
2017
Q2 		$246M Sell
3,060,572
-1,369,719
-31% -$108M 0.17% 131
2017
Q1 		$348M Sell
4,430,291
-1,239,278
-22% -$98.9M 0.25% 84
2016
Q4 		$447M Sell
5,669,569
-229,329
-4% -$18.6M 0.33% 61
2016
Q3 		$525K Sell
5,898,898
-920,982
-14% -$86.9M 0.33% 67
2016
Q2 		$653M Buy
6,819,880
+51,493
+0.8% +$5.13M 0.5% 44
2016
Q1 		$702M Sell
6,768,387
-591,180
-8% -$57.5M 0.54% 38
2015
Q4 		$720M Sell
7,359,567
-1,087,380
-13% -$106M 0.54% 36
2015
Q3 		$815M Sell
8,446,947
-403,272
-5% -$42.4M 0.64% 25
2015
Q2 		$928M Sell
8,850,219
-361
-0% -$36.9K 0.66% 24
2015
Q1 		$913M Buy
8,850,580
+201,512
+2% +$20.4M 0.64% 27
2014
Q4 		$833M Buy
8,649,068
+60,675
+0.7% +$5.35M 0.58% 28
2014
Q3 		$684M Buy
8,588,393
+262,295
+3% +$20.7M 0.49% 38
2014
Q2 		$628M Buy
8,326,098
+1,475,947
+22% +$112M 0.44% 41
2014
Q1 		$513M Buy
6,850,151
+362,242
+6% +$25.6M 0.37% 49
2013
Q4 		$464M Buy
6,487,909
+912,980
+16% +$58.7M 0.33% 57
2013
Q3 		$316M Sell
5,574,929
-171,494
-3% -$10.2M 0.25% 85
2013
Q2 		$329M Buy
+5,746,423
New +$333M 0.27% 82

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TIAA CREF Investment Management's CVS Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its CVS Health (CVS) stake by 21% in Q1 2019, selling an estimated $109M and leaving 6,842,868 shares worth $369M. The position accounts for 0.26% of the portfolio, ranked #75.

TIAA CREF Investment Management first reported a position in CVS in Q2 2013 and has held it in 24 quarters since. The position peaked at $928M in Q2 2015. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • TIAA CREF Investment Management held 6,842,868 shares of CVS Health worth $369M as of Q1 2019.
  • TIAA CREF Investment Management sold 1,768,121 CVS Health shares in Q1 2019, an estimated $109M.
  • CVS Health made up 0.26% of TIAA CREF Investment Management's portfolio in Q1 2019, its #75 holding.
  • TIAA CREF Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's CVS Health position peaked at $928M in Q2 2015.
  • 1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.